The gold contract closes up 0.4% on Friday (Dec. 17) amid concerns about the spread of COVID-19 omicron species. Investors continue to buy gold as a safe haven and hedge against the uncertainties that could bring the change in monetary policy.
Gold futures rose 0.4% to close at $1,804.90 per ounce.
Today’s rise in the price of gold was also helped by the depreciation of the dollar and the decline in U.S. government bond yields.
WHO provides preliminary evidence that the covid-19 vaccine may be less effective in preventing infection and the spread of omicron strains. There continues to be confusion here, as some mainstream media previously reported that a third vaccination might provide good protection.
In addition, a study by the University of Washington and the Swiss pharmaceutical company Humabs Biomed SA found that Chinese Sinofarm vaccines, U.S. Johnson & Johnson vaccines, and other vaccines were more effective in building immunity to the COVID-19 virus species Omicron than the vaccine produced by the U.S. pharmaceutical company Humabs Biomed SA and the Russian Sputnik.
Antibody tests on fully vaccinated subjects from Pfizer/Biontec, Moderna, Sinofarm, Johnson & Johnson, Sputnik, and AstraZeneca, however, showed low antibodies.
The Spot Market is Closed
Saturday, December 18, 2021
| Metals Updated at | USD Bid/Ask | Ounce Change | Low/High |
| Gold 05.00 | 1,798.70 1,799.70 | -0.60 -0.03% | 1,796.60 1,817.30 |
| Silver 05.00 | 22.35 22.45 | -0.12 -0.53% | 22.34 22.75 |
| Platinum 05.00 | 937.00 947.00 | 0.00 0.00% | 931.00 958.00 |
| Palladium 05.00 | 1,718.00 1,868.00 | +49.00 2.94% | 1,649.00 1,948.00 |
| Rhodium 05.00 | 12,900.00 14,900.00 | +50.00 0.39% | 12,850.00 14,900.00 |